Teladoc Health Inc (TDOC) Stock Experiences 4.54% Monthly Change

BLFR

In the past week, TDOC stock has gone up by 7.74%, with a monthly gain of 4.54% and a quarterly plunge of -17.11%. The volatility ratio for the week is 3.18%, and the volatility levels for the last 30 days are 2.79% for Teladoc Health Inc. The simple moving average for the past 20 days is 3.51% for TDOC’s stock, with a -17.30% simple moving average for the past 200 days.

Is It Worth Investing in Teladoc Health Inc (NYSE: TDOC) Right Now?

The 36-month beta value for TDOC is also noteworthy at 1.78. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 2 rating it as “overweight,” 19 rating it as “hold,” and 0 rating it as “sell.”

The public float for TDOC is 173.63M, and at present, short sellers hold a 12.44% of that float. The average trading volume of TDOC on June 09, 2025 was 5.41M shares.

TDOC) stock’s latest price update

Teladoc Health Inc (NYSE: TDOC)’s stock price has gone rise by 1.81 in comparison to its previous close of 7.27, however, the company has experienced a 7.74% increase in its stock price over the last five trading days. globenewswire.com reported 2025-06-05 that NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) — Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, and Mala Murthy, chief financial officer, will participate in the Goldman Sachs 46th Annual Global Healthcare Conference in Miami on Wednesday, June 11th, 2025, at 9:20 a.m. ET. A live audio webcast and replay of the presentation will be available at http://ir.teladochealth.com/news-and-events/events-and-presentations.

Analysts’ Opinion of TDOC

Many brokerage firms have already submitted their reports for TDOC stocks, with Goldman repeating the rating for TDOC by listing it as a “Buy.” The predicted price for TDOC in the upcoming period, according to Goldman is $14 based on the research report published on November 15, 2024 of the previous year 2024.

Jefferies, on the other hand, stated in their research note that they expect to see TDOC reach a price target of $10, previously predicting the price at $8. The rating they have provided for TDOC stocks is “Hold” according to the report published on September 17th, 2024.

Cantor Fitzgerald gave a rating of “Overweight” to TDOC, setting the target price at $22 in the report published on February 29th of the previous year.

TDOC Trading at 2.82% from the 50-Day Moving Average

After a stumble in the market that brought TDOC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -51.34% of loss for the given period.

#####

#####

Insider Trading

Reports are indicating that there were more than several insider trading activities at TDOC starting from Rodrigues Fernando M., who sale 4,174 shares at the price of $6.91 back on Jun 03 ’25. After this action, Rodrigues Fernando M. now owns 0 shares of Teladoc Health Inc, valued at $28,842 using the latest closing price.

Rodrigues Fernando M., the President of BetterHelp of Teladoc Health Inc, sale 2,358 shares at $6.86 during a trade that took place back on Jun 02 ’25, which means that Rodrigues Fernando M. is holding 4,174 shares at $16,176 based on the most recent closing price.

Stock Fundamentals for TDOC

Current profitability levels for the company are sitting at:

  • -0.1 for the present operating margin
  • 0.67 for the gross margin

The net margin for Teladoc Health Inc stands at -0.4. The total capital return value is set at -0.11. Equity return is now at value -54.49, with -26.07 for asset returns.

Based on Teladoc Health Inc (TDOC), the company’s capital structure generated 0.53 points at debt to capital in total, while cash flow to debt ratio is standing at 0.19. The debt to equity ratio resting at 1.11. The interest coverage ratio of the stock is -10.97.

Currently, EBITDA for the company is -587.01 million with net debt to EBITDA at -0.54. When we switch over and look at the enterprise to sales, we see a ratio of 0.66. The receivables turnover for the company is 10.96for trailing twelve months and the total asset turnover is 0.74. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.65.

Conclusion

In summary, Teladoc Health Inc (TDOC) has had a mixed performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Most Popular

Related Posts

favicon-nh
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.